Unlock instant, AI-driven research and patent intelligence for your innovation.

Porous degradable polyelectrolyte microspheres as vaccine vector

A polyelectrolyte, polyol technology, applied in the fields of pharmaceutical technology, molecular biology and immunology

Inactive Publication Date: 2013-07-10
UNIV GENT
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, when the resulting particles are mixed in water, for example, to be administered into the body by injection, their typical behavior is to aggregate to create a clot or dissolve to leave most drugs in soluble form, which is undesirable in the present case of
Also, it is not predictable whether the amorphous or crystalline state of the particle components will remain the same after spray drying

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Porous degradable polyelectrolyte microspheres as vaccine vector
  • Porous degradable polyelectrolyte microspheres as vaccine vector
  • Porous degradable polyelectrolyte microspheres as vaccine vector

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0155] Embodiment 1: the synthesis of solid microsphere

[0156] Dextran sulfate (DEXS; 10kDa), poly-L-arginine (P L ARG, 100 kDa), ovalbumin (OVA; grade VII) and mannitol were obtained from Sigma-Aldrich. OVA-alexa488 and LysoTracker Red were obtained from Invitrogen. All water used in the experiments was Milli-Q grade.

[0157] Mannitol was mixed with dextran sulfate (DS) and ovalbumin (OVA; used as a model antigen in this study) in water at a ratio of 40 / 4 / 1 / 5 at 1% total solids under agitation. Concentration mix. In detail, 200 mg of mannitol, 20 mg of DS and 5 mg of OVA were dissolved in 20 ml of water. Then P L ARG was dissolved in 5 ml of water and added dropwise to the stirred mannitol / DS / OVA solution to allow L Electrostatic recombination between ARG and DS and OVA, respectively.

[0158] The mixture was then spray dried using a B290 benchtop spray dryer and collected as a dry powder. This mixture was fed into a two-fluid nozzle (diameter: 0.7 mm) on top of th...

Embodiment 2

[0159] Example 2: Particle Characterization

[0160] The morphology of the solid microspheres ( FIG. 2A ) and the porous microspheres obtained after extraction of mannitol in water ( FIG. 2B ) were visualized by scanning electron microscopy (SEM).

[0161] Most importantly, as will be suggested in more detail below by confocal microscopy, the spray-dried microspheres remain stable and do not break down into the original starting components when resuspended in an aqueous medium. As a control, we also spray dried a mixture of mannitol and OVA and observed immediate dissolution of the microparticles upon addition of water (data not shown), suggesting the need for DS / P L ARG polyelectrolyte complex framework to obtain stable microspheres. Extraction of mannitol in water leads to the formation of porous microspheres that are likely stabilized via a combination of electrostatic and hydrophobic interactions and physical entanglements between polymer and protein chains.

[0162] Con...

Embodiment 3

[0163] Embodiment 3: the mensuration of encapsulation efficiency

[0164] Quantification of encapsulation efficiency was determined by individually resuspending dried solid microspheres in phosphate buffered saline (PBS; pH 7.4). Subsequently, the microspheres were centrifuged and the OVA concentration in the supernatant was determined. When the encapsulation efficiency is defined as the amount of protein retained within the microspheres after resuspension relative to the amount of protein in the dried microspheres, an encapsulation efficiency of 100 ± 1% after resuspension in PBS was observed. This value means that no detectable amount of OVA was released from the porous microspheres following the extraction of mannitol from the microspheres after resuspension in PBS. The encapsulation efficiency of 100% into porous polyelectrolyte spheres was significantly higher than the ~50% encapsulation efficiency of the previous encapsulation of OVA into hollow polyelectrolyte multilay...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The present invention discloses a composition comprising a polyelectrolyte complex and a polyol, characterised in that said polyol is in amorphous form. Optionally, the composition further comprises one or more drugs, wherein each drug has a molecular weight of at least 1000 Dalton. Said compositions are obtainable by spray-drying. The compositions may be prepared in particle form and as a suspension of particles. Pharmaceutical compositions are also provided for use in extracellular drug delivery. Pharmaceutical compositions are also provided that exhibit a controlled dual drug release.

Description

field of invention [0001] The invention belongs to the fields of pharmaceutical technology, molecular biology and immunology. Background of the invention [0002] In the last decade, with the advent of molecular biology techniques, the development of biopharmaceuticals has progressed rapidly. Synthetic vaccines designed to prime the adaptive immune system are sought for a wide range of diseases including infectious diseases and cancer, both prophylactically and therapeutically. [0003] Priming of the adaptive immune system requires the induction of both T-cell and B-cell responses, which are triggered by two different pathways. T cell activation occurs when the cellular intermediate dendritic cells internalize the protein, proteolyze the antigen into short peptides, and present these peptides to the cleft of the T cell major histocompatibility complex (MHC) molecule. B cells, on the other hand, can directly bind protein antigens via their B cell receptors (membrane-bound...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/16A61K39/385A61K47/26
CPCA61K9/0019A61K9/0024A61K9/1617A61K9/1623A61K9/1641A61K39/385A61K2039/55555A61J3/00A61K9/14A61K47/10A61K47/36A61K47/42
Inventor J.P.雷蒙B.德格斯特S.德科克尔J.格罗滕C.弗瓦埃特
Owner UNIV GENT